PTEN acts as a tumour suppressor gene both by inhibiting the PI3K/Akt pathway, and by acting as a negative regulator of HIF-1α (hypoxia-inducible factor-1) [38,39]. The gene discussed is HIF1A; the disease is neoplasm.